Extended Data Fig. 6: Binding of anti-SARS-CoV-2 monoclonal antibodies to Vero cells infected with the SARS-CoV-2 variants D614G, Alpha, Beta and Delta.
From: Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Vero cells were infected with the indicated variants at a MOI of 0.1. After 48 h, cells were stained with anti-SARS-CoV-2 monoclonal antibodies (1 μg ml−1) and analysed by flow-cytometry. a, Gating strategy. b, Histograms show the binding of bamlanivimab, imdevimab and RBD-85 to Vero cells infected with the indicated variants. c, Radar charts represent for each antibody the logarithm of the mean of fluorescent intensity of the staining, relative to the non-infected condition. Data are representative of three independent experiments.
